Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 6Phase 1/2 4Phase NA 2Phase 2/3 2Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 49Thoracic 26Breast 16Gynecologic 8CNS 7Other hematologic neoplasm 6Lymphoid 6Genitourinary 5Other solid neoplasm 4Head & Neck 4Tumor-Agnostic 2Sarcoma 2Plasma cell 2Dermatologic 2Classical hematology 2Other neoplasm 1NET 1Myeloid 1Endocrine 1

Conditions

Sarcoma, Ewing 1Desmoid Tumors 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Drug Therapy × Sarcoma × Clear all
NCT07188532 2026-05-11

BEAR

Mayo Clinic

Phase NA Recruiting
141 enrolled
Sarcoma

Sarcoma, Ewing

NCT05490667 2023-10-30

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Henan Cancer Hospital

Phase NA Unknown
30 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡